Intelligent Bio Solutions Inc (INBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,605 | -10,191 | -10,665 | -8,334 | -7,060 |
| Depreciation Amortization | 970 | 974 | 4,973 | N/A | N/A |
| Accounts receivable | -165 | -136 | -294 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,577 | -633 | 85 | 243 | -973 |
| Other Working Capital | -721 | -702 | 79 | 2,439 | -4,941 |
| Other Operating Activity | -1,734 | 1,116 | -1,556 | 2,294 | 1,677 |
| Operating Cash Flow | $-9,677 | $-9,572 | $-7,377 | $-3,358 | $-11,297 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -232 | -221 | -505 | -380 | N/A |
| Net Acquisitions | N/A | N/A | -189 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -500 | 0 |
| Investing Cash Flow | $-232 | $-221 | $-694 | $-880 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,598 | 14,561 | 2,555 | N/A | 22,112 |
| Other Financing Activity | 0 | 0 | -1,119 | 0 | 1,291 |
| Financing Cash Flow | $4,598 | $14,561 | $1,435 | $N/A | $23,403 |
| Exchange Rate Effect | 27 | -1 | -65 | -97 | 40 |
| Beginning Cash Position | 6,304 | 1,537 | 8,238 | 12,574 | 427 |
| End Cash Position | 1,020 | 6,304 | 1,537 | 8,238 | 12,574 |
| Net Cash Flow | $-5,284 | $4,767 | $-6,701 | $-4,335 | $12,146 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,677 | -9,572 | -7,377 | -3,358 | -11,297 |
| Capital Expenditure | -232 | -221 | -505 | -380 | N/A |
| Free Cash Flow | -9,909 | -9,793 | -7,883 | -3,738 | -11,297 |